Page 3 - Cough Syrup

Gambia police investigate children' deaths linked to Indian cough syrup

Police in Gambia are investigating the deaths of 66 children, which have been linked to four brands of imported Indian cough syrup, the media reported

Maiden Pharma may lose import-export code over cough syrup deaths in Gambia

Pharmexcil suspends membership; may recommend DGFT to withdraw Import-Export Code

Maiden Pharmaceuticals breaks silence on cough syrup deaths in Gambia

The pharma company Maiden Pharmaceuticals has come under scanner after 66 children died in the Gambia after consuming cough syrup produced in India

WHO alert on cough syrups alarming, missing links need to be probed: Expert

The WHO's recent alert linking cough syrups manufactured by an Indian pharmaceutical firm to the deaths of children in Gambia is "alarming" and there are some missing links that need to be "investigated", an expert said on Saturday. The World Health Organisation on Wednesday issued an alert, saying four "contaminated" and "substandard" cough syrups produced by Maiden Pharmaceuticals Limited could be the reason for the deaths in the West African nation. The four products are Promethazine Oral Solution, Kofexmalin Baby Cough Syrup, Makoff Baby Cough Syrup and Magrip N Cold Syrup. "The information from WHO that cough syrups manufactured by an Indian pharma company caused the death of 66 children due to the presence of ethylene glycol is alarming. "There are, however, some missing links that need to be carefully ascertained and investigated," said Professor Y K Gupta, senior pharmacologist and vice chairman of the Standing National Committee on Medicines (SNCM). Dr Gupta said the firs

Advisory board urges ban on codeine cough drugs, regulator to take call

Codeine formulations constitute 8% of cough and cold market; pharma industry asks govt not to ban a 'safe' medicine for abuse by some

Govt must fix accountability: Anand Sharma on 'cough syrups-linked' deaths

Senior Congress leader Anand Sharma on Friday hit out at the Centre over the deaths of children in Gambia allegedly due to the consumption of cough syrups manufactured by an Indian firm, and asked the government to fix accountability. The World Health Organisation (WHO) on Wednesday warned that four "contaminated" and "substandard" cough syrups allegedly produced by Maiden Pharmaceuticals Limited based in Haryana's Sonepat could be the reason for the deaths in the West African nation. India's drug regulator Drugs Controller General of India (DCGI) has already initiated a probe and sought further details from the WHO. In a statement on the issue, former commerce and industry minister Anand Sharma said the deaths of dozens of children in Gambia "due to consumption of Cough syrup made by an Indian company Maiden Phamaceuticals has shocked the word". "This is a monumental tragedy that raises serious concerns as conveyed by WHO and also questions which, must be answered. The bland ...

Who is responsible for the quality of Indian pharma exports?

WHO has issued a global alert over four cough syrups made by an Indian pharma company, for alleged death of 66 children in The Gambia. Who are responsible for quality checks of Indian pharma exports?

Top headlines: Growth forecast, Maiden Pharma cough syrup issue, and more

From World Bank slashing India's economic growth to Maiden Pharma's cough syrup issue, here are the top headlines on Friday morning

Who is responsible for the quality of Indian pharma exports?

WHO has issued a global alert over four cough syrups made by an Indian pharma company, for alleged death of 66 children in The Gambia. Who are responsible for quality checks of Indian pharma exports?

Maiden Pharma's cough syrups, under WHO scanner, not sold in India: Sources

Meanwhile, the Indian regulator is awaiting evidence of links between the cough syrups and the deaths in Gambia

Controversial cough syrup maker Maiden Pharmaceuticals has global presence

Maiden Pharmaceuticals, which is under the lens of regulators after the WHO issued an alert saying the firm's cough syrups could potentially be linked to the death of children in The Gambia, has its global presence mostly in Africa, South America and South East Asia. As per its website, the company has its corporate office at Pitampura in the National Capital with two manufacturing units in Haryana -- one at Kundli and another at Panipat. It claims to be a WHO-GMP & ISO 9001-2015 certified pharmaceutical company. The company had started operations on November 22, 1990. Maiden Pharmaceuticals' global presence has a strong concentration in Africa, including countries such as Algeria, Senegal, Nigeria, Cameroon, Kenya and Tanzania. In South East Asia also it has presence in countries such as Laos, Vietnam, Thailand, Cambodia, the Philippines, Malaysia and Indonesia, among others. The company's footprints in South America include Ecuador, Chile, Venezuela, Surinam and Paraguay, ...

CDSCO takes up investigation on WHO's complaint for India-made cough syrups

After the World Health Organization issued an alert on four India-made cough and cold syrups used for paediatric groups, the Central Drugs Standard Control Organisation has taken up an urgent probe

Cough syrups by Indian firm potentially tied to 66 deaths in Gambia: WHO

WHO issued a medical product alert for the four syrups and said it was conducting further investigation with New Delhi-based Maiden Pharmaceuticals and regulatory authorities in India

Centre looking to phase out codeine-based cough syrups, select FDCs

The industry is divided on the issue of phasing out codeine-based cough syrups, which are used by many as intoxicants

Despite cough syrup ban, doctors echo granny, say hot water works just as well

Despite the ban on Corex and Phensedyl, experts say market won't crash because of hundreds of cough syrup brands